Markets:

Overview

News

Currencies

International

Treasuries

Vanguard Extended Market ETF (NY:VXF)

206.88 -3.12 (-1.49%)

Streaming Delayed Price Updated: 12:55 PM EDT, Mar 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vanguard Extended Market ETF

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

VELO Stock Rallies More Than 20% On Significant Debt Reduction — Retail Cheers Insider Confidence ↗

March 11, 2026

Velo3D’s CEO Dr. Arun Jeldi purchased a $5 million promissory note from an existing debt holder and converted the same into common stock at $16.38 per share.

Via Stocktwits

Groupon Stock Fell 11% After Hours – Here’s Why ↗

March 10, 2026

The company said its revenue was $132.7 million in the fourth quarter 2025, below analyst expectations of $136.7 million, as per data from Fiscal.ai.

Via Stocktwits

QURE Stock Edges Up After Hours As Analyst Flags Reduced Regulatory Uncertainty Following Prasad’s FDA Exit ↗

March 10, 2026

Mizuho said that Dr. Vinay Prasad’s exit just days after a highly public dispute with uniQure appeared to signal an administration-level desire to restore greater regulatory flexibility in rare disease...

Via Stocktwits

MGNX Closes Up 45% On Wall Street Optimism For Experimental Cancer Therapies ↗

March 10, 2026

Barclays increased the price target on the stock to $4 from $3 and kept an ‘Overweight’ rating on the shares.

Via Stocktwits

Why Did INKT Stock Surge 70% In Pre-Market Today? ↗

March 10, 2026

MiNK Therapeutics tied up with an oncology consortium to develop a cell therapy targeting pediatric cancers.

Via Stocktwits

This Overlooked Vanguard ETF Could Quietly Outperform the S&P 500 Over the Next 5 Years ↗

March 09, 2026

Investors have ridden tech stocks and the S&P 500 for years. But the time for large-caps might finally be coming to an end.

Via The Motley Fool

TRVI Stock Slips After Company Plans Parallel Trials In Lung Disease — Stifel Dismisses Timeline Concerns ↗

March 09, 2026

The company announced its decision following a meeting with the U.S. Food and Drug Administration.

Via Stocktwits

ANTX Stock Records Biggest Ever Single Day Gain, Surges 500% Over Past Four Sessions – What Triggered This Smashing Rally? ↗

March 09, 2026

AN2 Therapeutics shares more than doubled in value on Monday after the company announced a private placement to raise about $40 million.

Via Stocktwits

BBAI Shares Climb After Having Declined 25% This Year — Retail Says Buy Now To Triple Your Money ↗

March 06, 2026

BigBear.ai Holdings posted a 38% decline in Q4 revenue to $27.3 million earlier this week, compared to Wall Street’s estimates of $33.3 million, according to data from Fiscal.ai.

Via Stocktwits

ONDS Stock Jumps 8% Following $6 Million Deal For Its Drone Systems – Retail Sees Validation In Repeat Orders ↗

March 06, 2026

The company announced multiple orders worth for its counter-drone systems, bringing the total to $26 million in March.

Via Stocktwits

Rumble Stock Is Diving After Hours – What Happened To Q4 Revenue? ↗

March 05, 2026

The decline in Q4 revenue was attributable to a decrease in Audience Monetization revenues and lower Other Initiatives revenues. The revenue was in line with analyst expectations, per Fiscal.ai.

Via Stocktwits

Owlet Stock Is Down 26% After Hours – How Did The Company’s Q4 Results Fare? ↗

March 05, 2026

Owlet said that for the first quarter of 2026, it expects revenue in the range of $20 to $21 million. The forecast was significantly lower than Wall Street expectations of $26.2 million.

Via Stocktwits

EONR Stock Is Rallying On Oil Price Spike – What Does Retail Think? ↗

March 05, 2026

U.S. crude oil prices jumped beyond $80 per barrel mark and reached a 52-week high according to data from CNBC.

Via Stocktwits

Topics Energy

Why Did OSRH Stock Jump 20% Today? ↗

March 05, 2026

The company received an additional 180-day extension from Nasdaq to regain compliance after receiving an initial notice on Sept. 9, 2025.

Via Stocktwits

Why Did IBO Stock Surge 65% In Pre-Market Today? ↗

March 05, 2026

The company announced amendments to agreements related to its planned merger with Dr. Ashley's, including extending the deadline to complete the merger to July 1, 2026.

Via Stocktwits

Topics Intellectual Property

Why Did BTAI Stock Surge 20% In Pre-Market Today? ↗

March 05, 2026

BioXcel announced positive Phase 2 results for evaluating treatment for opioid withdrawal symptoms.

Via Stocktwits

BIO-key Discloses Orders From A ‘Foreign Defense Ministry’ – But Stock Loses Initial Gains ↗

March 05, 2026

The company, however, did not disclose the organization's name but stated that it currently supports more than 50,000 licensed users for the ministry.

Via Stocktwits

ASTS Surges Amid Price Target Hikes, Telus Partnership — Here’s Why UBS Is Bullish On The Stock ↗

March 04, 2026

UBS analyst Christopher Schoell highlighted that AST SpaceMobile’s revenue is expected to multiply as the company’s commercial service launch draws closer.

Via Stocktwits

MBOT Stock Falls As Investors Ponder Impact Of Geopolitical Tensions On Israel-Founded Company ↗

March 03, 2026

Microbot said on Tuesday that it is not experiencing any disruption in either the U.S. or Israel with all personnel continuing to operate as usual.

Via Stocktwits

ATRA Rises On Pushing For Meeting With FDA On Rare Disease Drug Rejection ↗

March 03, 2026

FDA refused approval for tabelecleucel in treating patients two years of age and older with Epstein-Barr virus positive post-transplant lymphoproliferative disease earlier this year.

Via Stocktwits

Battalion Oil Stock More Than Doubles — Retail Sees Hormuz Strait Closure As The ‘Worst Case Scenario’ For Oil ↗

March 02, 2026

Iran’s Revolutionary Guards commander has reportedly said that the Strait of Hormuz is closed, The Guardian reported. citing Iranian state media.

Via Stocktwits

AARD Stock Slumps 54% Pre-Market – Here’s Why Analysts Are Not ‘Comfortable’ With The Suspension Of A Key Phase 3 Trial ↗

March 02, 2026

Aardvark Therapeutics shares saw brokerage downgrades after the company paused its Phase 3 trial to treat hyperphagia in patients with Prader-Willi syndrome.

Via Stocktwits

Hawaiian Electric Shares Are Higher Today – Know Why ↗

February 27, 2026

The company said that its fourth quarter 2025 net income was $40 million, or $0.23 per share, compared to a net loss of $68 million, or $0.40 per share in 2024.

Via Stocktwits

Truth Social Spinoff — DJT Stock Rises As Trump Media Explores Public Listing Deal For The Platform ↗

February 27, 2026

Trump Media added that the shares of Truth Social would be distributed to its shareholders of record prior to the closing of the merger with TAE.

Via Stocktwits

Topics Government

KORE Stock Is Ripping Pre-Market Today After Company Agrees To A Deal To Take It Private ↗

February 27, 2026

KORE stated that Searchlight and Abry will acquire all shares of the company’s issued and outstanding common stock that they currently don’t own in an all-cash transaction valued at nearly $726...

Via Stocktwits

AAOI Stock On Track To Open At Over 8-Year Highs: B. Riley Upgrade, Retail Optimism Drive Rally ↗

February 27, 2026

The company reported a 34% jump in fourth-quarter revenue to $134.3 million, beating Wall Street’s estimates of $128.2 million, according to Fiscal.ai data.

Via Stocktwits

Topics Regulatory Compliance

MARA Stock Is Rallying Today – What Is All The Buzz About? ↗

February 26, 2026

MARA Holdings announced it has entered into a strategic agreement with Starwood Capital Group and their dedicated data center development platform Starwood Digital Ventures.

Via Stocktwits

Topics Artificial Intelligence

Why Did OCGN Stock Rise Today? ↗

February 25, 2026

Ocugen said that it intends to start seeking the approval of the FDA for its experimental therapy OCU400 starting this year.

Via Stocktwits

LGVN Shares Rise After Investigational Therapy Shows Improvement In Age-Related Frailty In Study ↗

February 25, 2026

Longeveron said that intravenous laromestrocel improved the physical condition of patients with age-related clinical frailty after nine months, compared to placebo.

Via Stocktwits

Why Did INBS Stock Jump 11% In Pre-Market Today? ↗

February 25, 2026

The company announced the first shipment of its Intelligent Fingerprinting Drug Screening Readers, produced in collaboration with Syrma Johari MedTech.

Via Stocktwits

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.